Crinetics Pharmaceuticals OverviewCrinetics Pharmaceuticals Net Income
Profitability analysis for CRNX.
Quarterly Net Income
-$127.84M
↓ 32.11% YoY
As of Mar 2026
Annual Net Income (TTM)
-$496.39M
↓ 51.22% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...